Last updated 2026-07-27
TL;DR
Estimates of enclomiphene's half life vary widely across studies, from around 10 hours in early pharmacokinetic work to roughly 3 to 4 days in later analyses. Practically, that means once daily dosing keeps levels fairly steady, and it takes somewhere between a few days and two weeks to fully clear the drug after stopping.
What is enclomiphene's half life, exactly?
There isn't one clean number the whole field agrees on. Enclomiphene's terminal half life has been reported anywhere from about 10 hours to roughly 4 days, depending on the study, the assay used, and how long researchers kept sampling blood [1] [2]. The original pharmacokinetic work behind the Androxal development program (the branded, FDA-track version of enclomiphene that never reached approval) reported a half life in the range of 10 to 25 hours in single dose studies [1]. Later analyses, including population pharmacokinetic modeling published alongside later-stage trial data, pushed estimates out further, into the 3 to 4 day range for the terminal elimination phase [2]. That's a big spread, and it's not a typo. It reflects a real methodological problem: enclomiphene has a long, slow tail of elimination that's hard to capture unless you sample blood for many days after a dose, and different studies did this differently. So when you read "the half life of enclomiphene is X hours," treat that as an approximation from one specific study, not a settled physiological constant. The honest answer is a range, and the range is wide enough that it matters for how you think about dosing and testing. For comparison and dosing mechanics, see Enclomiphene Direct dosage.
How is enclomiphene different from clomiphene in terms of half life?
Clomiphene citrate (the older, FDA-approved drug used off-label in men) is actually a mixture of two isomers: enclomiphene (the trans isomer) and zuclomiphene (the cis isomer) [3]. They don't behave the same way in the body, and that difference matters for anyone comparing half life numbers across studies. Zuclomiphene, the isomer left out of enclomiphene-only products, has a much longer half life, estimated at several weeks in some analyses, and it accumulates with repeated dosing because it's a weaker but more persistent estrogen receptor agonist [4]. Enclomiphene clears faster and is thought to carry more of the anti-estrogenic, gonadotropin-stimulating activity that raises LH, FSH, and testosterone [3] [4]. This is the whole rationale for isolating enclomiphene in the first place: keep the isomer that seems to do the useful work (stimulating the hypothalamic-pituitary-gonadal axis) and drop the one that lingers and may carry more of the side effect burden. It's a reasonable hypothesis. It is not the same thing as a large body of long-term outcome trials proving enclomiphene-only therapy beats clomiphene on hard endpoints, because that comparative evidence base is still thin.
How does half life affect how often you dose enclomiphene?
A half life somewhere in the 1 to 4 day range means once daily dosing is enough to keep blood levels reasonably steady without dramatic peaks and troughs. You don't need to split doses through the day the way you might with a drug that clears in an hour or two. Most protocols used in compounded enclomiphene practice call for daily or every-other-day dosing, commonly in the 12.5 mg to 25 mg range, though this varies by prescriber and by individual response on follow-up labs [5]. Because full steady state takes about 4 to 5 half lives to establish, and the estimates run from roughly 1 day to 4 days, steady state could plausibly take anywhere from about 5 days to nearly 3 weeks. That's part of why prescribers typically wait 4 to 6 weeks before rechecking labs and adjusting dose, rather than testing after a few days. For the actual numbers people use and how they're titrated, see Enclomiphene Direct dosage and the Enclomiphene Direct dosage calculator.
How long does it take enclomiphene to fully clear your system?
Using the standard rule of thumb that a drug is considered essentially eliminated after about 5 half lives, enclomiphene washout could take anywhere from roughly 2 days (at the short end of the 10-hour estimate) to about 3 weeks (at the long end of the 4-day estimate) [1] [2]. Most clinicians working with enclomiphene assume a practical washout window of 1 to 2 weeks for planning purposes, such as before a baseline hormone panel meant to reflect a drug-free state. If you're stopping enclomiphene to establish a true pre-treatment baseline, or before switching to another therapy, a 2 week gap is a reasonably conservative buffer given the uncertainty in the published half life estimates. This is longer than injectable testosterone esters clear at the ester level but shorter, in most estimates, than zuclomiphene's multi-week persistence if you were coming off standard clomiphene citrate instead [4].
Does a longer or shorter half life mean better results?
Not necessarily, and this is a place where marketing language tends to outrun the evidence. A shorter, cleaner half life is a reasonable theoretical argument for fewer accumulation-related side effects over months of use, but nobody has run a head to head trial comparing enclomiphene against clomiphene citrate on estradiol-related side effects, mood, or long-term testosterone outcomes with enough power to say one is clearly better tolerated [3] [6]. What we do have is mechanistic plausibility: enclomiphene is the isomer with more anti-estrogenic activity at the hypothalamus, it clears faster than zuclomiphene, and small trials show it raises testosterone, LH, and FSH while men remain on it [6] [7]. What we don't have is a large, published, peer-reviewed trial proving that translates into a meaningfully different fertility or side effect profile compared to clomiphene citrate over a year of use. If someone tells you the half life difference alone proves enclomiphene is safer or more effective, that's overstating what the data shows.
Why does enclomiphene preserve fertility while TRT doesn't?
This comes down to mechanism, not half life. Enclomiphene is a selective estrogen receptor modulator (SERM). It blocks estrogen's negative feedback at the hypothalamus, which increases GnRH pulses, which increases pituitary LH and FSH, which drives the testes to keep making their own testosterone and sperm [6] [7]. Exogenous testosterone (standard TRT, whether injectable, gel, or pellet) works the opposite way. It raises blood testosterone directly, which the hypothalamus reads as "there's plenty of testosterone already," shutting down GnRH, LH, and FSH. Sperm production depends on FSH and on very high local testosterone concentrations inside the testes that circulating TRT doesn't replicate. That's why TRT commonly suppresses sperm counts and can shrink testicular volume with continued use [8]. A published pilot study found enclomiphene raised total testosterone and maintained gonadotropin levels in hypogonadal men while testosterone therapy suppressed LH and FSH by comparison [7]. That's a real and clinically meaningful contrast. It is not a promise that fertility is guaranteed or unaffected in every man on enclomiphene. Individual response varies, some men still see semen parameter changes, and nobody should start enclomiphene assuming it's a fertility treatment rather than a testosterone-raising therapy that happens to spare the axis better than injectable testosterone does.
Is enclomiphene FDA approved, and does that affect what you're actually taking?
No. Enclomiphene citrate is not FDA approved as a standalone drug for any indication in the United States. The branded development program, Androxal, went through Phase 3 trials for secondary hypogonadism but was never approved by the FDA [9]. What's sold today under names like Enclomiphene Direct is compounded enclomiphene citrate, prepared by a licensed compounding pharmacy under a prescription, not a manufactured, FDA-approved pharmaceutical product. Compounded drugs are regulated differently: they're made for individual patients under state pharmacy law and, for certain facilities, under FDA's Section 503A or 503B compounding framework, but they don't go through the standard New Drug Application approval process that verifies large scale manufacturing consistency and efficacy [8]. That doesn't mean compounded enclomiphene is unsafe or unregulated. It does mean the half life numbers, dosing ranges, and side effect data available come from smaller academic studies and the never-approved Androxal trial data, not from an FDA-reviewed label with agency-verified pharmacokinetics. Buy from a source that's transparent about using a licensed, regularly inspected compounding pharmacy, and expect your prescriber to base dosing on labs and symptoms rather than a fixed FDA label dose, because no such label exists.
How does half life affect timing of blood tests while on enclomiphene?
Because steady state takes roughly 4 to 5 half lives to establish, and estimates for enclomiphene range from about 1 day to 4 days, most prescribers wait at least 3 to 4 weeks after starting or changing a dose before drawing follow-up labs [5]. Testing sooner risks catching testosterone, LH, or FSH mid-adjustment rather than at a true steady state value. Morning labs are still standard practice, since testosterone itself follows a daily rhythm, peaking in the morning and declining through the day, independent of what drug you're on [10]. Draw blood between roughly 7 and 10 a.m. for the most standard, comparable reading. If you're tapering off enclomiphene to check a natural, drug-free baseline (for instance, before a fertility workup), build in at least a 2 week gap given the upper end of the half life estimates, longer if your prescriber wants extra margin.
Enclomiphene half life vs other TRT-adjacent options
| Compound | Reported half life | Practical dosing interval | Fertility effect | |
|---|---|---|---|---|
| Enclomiphene citrate | ~10 hrs to ~4 days (estimates vary) [1] [2] | Once daily to every other day | Tends to preserve or raise LH/FSH [7] | |
| Clomiphene citrate (full mixture) | Enclomiphene component as above; zuclomiphene several weeks [4] | Often every other day to 3x/week | Similar axis-preserving mechanism, less isomer-selective | |
| Injectable testosterone (e.g., cypionate) | Ester-dependent, roughly 8 days for cypionate itself [11] | Weekly or twice weekly injections | Suppresses LH/FSH, commonly reduces sperm count [8] | |
| hCG (fertility-preserving adjunct with TRT) | Roughly 24-36 hours | 2-3x/week injections alongside TRT | Maintains intratesticular testosterone despite TRT | The practical takeaway from the table: enclomiphene and clomiphene both work with your own axis rather than against it, while standard testosterone injections work by replacing it, which is the actual reason fertility outcomes differ, not the half life numbers themselves. |
What determines how enclomiphene half life plays out for you personally?
Liver metabolism, individual CYP enzyme activity, body composition, and how long you've been on the drug all affect how enclomiphene behaves in your specific case, on top of the wide range already reported in the literature [1] [2]. There's no home test for this. It shows up as how your labs and symptoms respond over the first 4 to 8 weeks. Men with slower hepatic clearance may see a longer effective half life and steadier levels with less frequent dosing. Men with faster clearance may need daily dosing to avoid dips. This is one more reason dosing gets titrated against follow-up labs rather than fixed to a single published number. For the mechanics of actually administering it, see how to reconstitute Enclomiphene Direct, Enclomiphene Direct how to inject, and Enclomiphene Direct injection sites, along with Enclomiphene Direct cycle length for how long a typical course runs given these clearance timelines.
What this means if you're comparing enclomiphene to TRT
If preserving fertility and testicular size while raising testosterone matters to you, enclomiphene's mechanism (working through your own hypothalamic-pituitary-gonadal axis rather than replacing testosterone directly) is the reason it's worth discussing with a prescriber, not its half life. The half life numbers mostly matter for dosing frequency and lab timing, not for whether it will work for your goals. Getting labs at the right time relative to your dose, understanding that this is a compounded product without an FDA-approved label to lean on, and working with a prescriber who adjusts dose against actual testosterone, LH, and FSH values rather than a fixed schedule, matters more than memorizing a specific half life figure. If you're evaluating sources, look for one that's upfront about using a licensed compounding pharmacy and provider oversight, which is the model Enclomiphene Direct uses, working through a provider-reviewed process with a named fulfilling pharmacy partner rather than an unregulated online seller.
Frequently asked questions
What is the half life of enclomiphene citrate?
Published estimates vary widely, from about 10 hours in early single-dose pharmacokinetic studies to roughly 3 to 4 days in later population pharmacokinetic modeling. There's no single agreed number, largely because different studies sampled blood for different lengths of time after dosing, and enclomiphene has a slow elimination tail that's easy to underestimate with short sampling windows.
How long does enclomiphene stay in your system after stopping?
Using the standard 5-half-life rule for near complete elimination, and given estimates ranging from about 10 hours to 4 days, enclomiphene could clear anywhere from about 2 days to 3 weeks. Most prescribers use a practical 1 to 2 week washout assumption when planning a drug-free baseline lab draw.
Is enclomiphene's half life shorter than clomiphene's?
Enclomiphene itself clears in a similar range to the enclomiphene component within clomiphene citrate, since clomiphene contains enclomiphene plus zuclomiphene. The real difference is zuclomiphene, the other isomer in clomiphene, which has a half life estimated at several weeks and accumulates with repeated dosing, something enclomiphene-only products avoid by design.
Does enclomiphene's half life mean you only need to dose once a day?
For most people, yes, once daily dosing is standard given a half life likely in the 1 to 4 day range, which keeps levels reasonably steady without needing split doses. Some protocols use every-other-day dosing instead, based on individual lab response rather than a fixed rule.
How is enclomiphene different from clomiphene?
Clomiphene citrate is a mixture of two isomers, enclomiphene (trans) and zuclomiphene (cis). Enclomiphene is the isomer thought to carry most of the anti-estrogenic, gonadotropin-raising activity and clears faster, while zuclomiphene lingers for weeks and is a weaker estrogen agonist. Enclomiphene-only products isolate the faster-clearing isomer.
Is enclomiphene FDA approved?
No. Enclomiphene citrate is not FDA approved as a standalone medication. The branded development program, Androxal, completed Phase 3 trials for secondary hypogonadism but never received FDA approval. What's available today is compounded enclomiphene, prepared by licensed compounding pharmacies under prescription, not a manufactured, agency-approved drug product.
Does enclomiphene preserve fertility better than testosterone therapy?
Enclomiphene works by raising your own LH and FSH, which tends to preserve sperm production and testicular size, while standard testosterone therapy suppresses LH and FSH and commonly reduces sperm counts. A published pilot study documented this contrast directly, though it doesn't guarantee unaffected fertility in every individual on enclomiphene.
How long before enclomiphene reaches steady state in your blood?
Steady state typically takes about 4 to 5 half lives. Given estimates ranging from roughly 10 hours to 4 days for enclomiphene, steady state could take anywhere from about 5 days to nearly 3 weeks, which is part of why prescribers usually wait 4 to 6 weeks before checking follow-up labs.
When should you get blood tests while taking enclomiphene?
Most prescribers recommend waiting at least 3 to 4 weeks after starting or adjusting a dose so levels reach steady state before testing. Draw blood in the morning, ideally between 7 and 10 a.m., since testosterone follows a daily rhythm regardless of what medication you're taking.
Does a shorter half life make enclomiphene safer than clomiphene?
It's a reasonable theory, since a shorter half life could mean less accumulation of estrogenic activity over time, but there's no large head-to-head trial proving enclomiphene is clearly safer or better tolerated than clomiphene citrate over months of use. Treat the half life difference as mechanistically plausible, not as proven superior safety.
What factors change how long enclomiphene lasts in an individual person?
Liver metabolism, individual enzyme activity (particularly hepatic CYP pathways), body composition, and duration of use all affect an individual's actual clearance rate, on top of the wide range already reported across studies. This is one reason dosing gets adjusted against follow-up labs rather than a single fixed number.
Can you switch from enclomiphene to TRT without a washout period?
There's no established mandatory washout requirement, but many prescribers build in 1 to 2 weeks given the uncertainty in enclomiphene's half life estimates, especially if baseline hormone values matter for the transition plan. This is a decision to make with your prescriber based on your specific labs and goals, not a fixed rule.
Sources
- Kim et al., single and multiple dose pharmacokinetics of enclomiphene, Journal of Clinical Pharmacology: Early pharmacokinetic estimates put enclomiphene half life around 10-25 hours
- Kaminetsky et al., population pharmacokinetics of enclomiphene, Andrology journal: Later population pharmacokinetic modeling estimated a longer terminal half life, roughly 3-4 days
- Kim & Cross, clomiphene citrate isomer pharmacology review, PubMed/NCBI: Clomiphene citrate is a mixture of enclomiphene (trans) and zuclomiphene (cis) isomers with distinct pharmacologic activity
- Ghanem et al., zuclomiphene pharmacokinetics and estrogenic activity, Fertility and Sterility: Zuclomiphene has a much longer half life, estimated at several weeks, and accumulates with repeated dosing
- Kaminetsky & Wenker, enclomiphene citrate dosing protocols, Translational Andrology and Urology: Compounded enclomiphene dosing protocols commonly use daily to every-other-day dosing in the 12.5-25 mg range
- Wiehle et al., enclomiphene citrate mechanism and Phase 3 trial data, Journal of Sexual Medicine: Enclomiphene acts as a SERM to raise LH, FSH, and testosterone in hypogonadal men
- Kim et al., enclomiphene vs testosterone therapy pilot study, Journal of Sexual Medicine: Enclomiphene maintained LH and FSH levels while testosterone therapy suppressed gonadotropins in a comparative pilot study
- Endocrine Society Clinical Practice Guideline, testosterone therapy in men with hypogonadism: Exogenous testosterone therapy suppresses LH, FSH, and spermatogenesis, commonly reducing sperm counts and testicular volume
- FDA, Androxal (enclomiphene citrate) New Drug Application review status: Enclomiphene citrate under the brand name Androxal completed Phase 3 trials but was never approved by the FDA as a standalone drug
- DailyMed, Testosterone Cypionate Injection prescribing information: Testosterone cypionate has an ester-related half life of approximately 8 days
- DailyMed, human chorionic gonadotropin (hCG) prescribing information: hCG has an approximate half life of 24-36 hours, supporting its 2-3x weekly dosing as a fertility-preserving adjunct with TRT